Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_assertion type Assertion NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_head.
- NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_assertion description "[We evaluated 6 groups of subjects twice (basal: before any treatment; 2nd: after at least 18 months): 42 hypertensives (H) with a family history of hypertension (F+) and 30 H without a family history of hypertension (F-) successfully treated with angiotensin-converting enzyme inhibitors and/or calcium channel blockers (2nd: 24-h BP < or = 130/80 mm Hg); 22 untreated (UT) HF+ and 18 UTHF- (2nd: 24-h BP >140 and/or 90 mm Hg); 18 normotensives F+ and 15 normotensives F-.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_provenance.
- NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_assertion evidence source_evidence_literature NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_provenance.
- NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_assertion SIO_000772 11443163 NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_provenance.
- NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_assertion wasDerivedFrom befree-2016 NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_provenance.
- NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_assertion wasGeneratedBy ECO_0000203 NP323091.RABUQGCOqa-ul5Mw9Y4mxEYAG-vi2MFqPuXkyHLgBOei0130_provenance.